|1.||Puri, Raj K: 3 articles (03/2009 - 05/2005)|
|2.||Kioi, Mitomu: 2 articles (03/2009 - 08/2006)|
|3.||Pitari, G: 1 article (03/2012)|
|4.||Koutris, I: 1 article (03/2012)|
|5.||Laurenti, G: 1 article (03/2012)|
|6.||Cinque, B: 1 article (03/2012)|
|7.||Mei, S: 1 article (03/2012)|
|8.||Galzio, R: 1 article (03/2012)|
|9.||Benedetti, E: 1 article (03/2012)|
|10.||Giansanti, F: 1 article (03/2012)|
05/10/2005 - "This study describes a novel AM-induced mechanism of tumor sensitization through the upregulation of functional IL-13R alpha 2 chain, an ideal target for the highly specific recombinant chimeric cytotoxin IL13-PE38."
03/15/2009 - "Retrovirus-mediated gene-transfer of IL-13Ralpha2 in HSC-3 into tongue tumors in vivo dramatically enhanced the antitumor activity of IL13-PE38, providing complete elimination of established tumors and prolonging survival of these animals. "
08/01/2006 - "tumors of mice bearing metastatic lung tumors with IL13-PE38 showed not only the reduction of treated s.c. "
08/01/2006 - "When animals with IL-13Ralpha2-expressing D5 tumor (right) were injected with IL13-PE38, right flank tumors expressing the IL-13Ralpha2 chain not only showed dramatic regression but contralateral tumors (left flank) also showed tumor regression. "
08/01/2006 - "Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors."
|2.||Glioblastoma (Glioblastoma Multiforme)
03/01/2012 - "Targeted toxins approaches against glioblastoma were under investigation in phase I and II clinical trials with several immunotoxins (IT)/ligand toxins such as IL4-Pseudomonas aeruginosa exotoxin A (IL4-PE, NBI-3001), tumour growth factor fused to PE38, a shorter PE variant, (TGF)alpha-TP-38, IL13-PE38, and a transferrin-C diphtheriae toxin mutant (Tf-CRM107). "
|3.||Mouth Neoplasms (Oral Cancer)
|4.||Melanoma (Melanoma, Malignant)
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|2.||Transferrin (beta 2 Transferrin)